413 related articles for article (PubMed ID: 15579174)
1. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
Robertson GS; Lee CJ; Sridhar K; Nakabeppu Y; Cheng M; Wang YM; Caron MG
Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174
[TBL] [Abstract][Full Text] [Related]
2. FosB in rat striatum: normal regional distribution and enhanced expression after 6-month haloperidol administration.
Rodríguez JJ; Garcia DR; Nakabeppu Y; Pickel VM
Synapse; 2001 Feb; 39(2):122-32. PubMed ID: 11180499
[TBL] [Abstract][Full Text] [Related]
3. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ
Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890
[TBL] [Abstract][Full Text] [Related]
4. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
Guo N; Vincent SR; Fibiger HC
Neuropsychopharmacology; 1998 Aug; 19(2):133-45. PubMed ID: 9629567
[TBL] [Abstract][Full Text] [Related]
6. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
8. D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration.
Muller DL; Unterwald EM
J Pharmacol Exp Ther; 2005 Jul; 314(1):148-54. PubMed ID: 15772255
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
10. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
Joyce JN
Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
[TBL] [Abstract][Full Text] [Related]
11. Effects of YM-43611, a novel dopamine D2-like receptor antagonist, on immediate early gene expression in the rat forebrain.
Kurokawa K; Narita M; Koshiya K; Hidaka K; Ohmori J; Satoh K
Neuropsychopharmacology; 1997 Jul; 17(1):27-33. PubMed ID: 9194047
[TBL] [Abstract][Full Text] [Related]
12. The use of stereological counting methods to assess immediate early gene immunoreactivity.
Mura A; Murphy CA; Feldon J; Jongen-Relo AL
Brain Res; 2004 May; 1009(1-2):120-8. PubMed ID: 15120589
[TBL] [Abstract][Full Text] [Related]
13. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
Hsieh HC; Li HY; Lin MY; Chiou YF; Lin SY; Wong CH; Chen JC
Synapse; 2002 Sep; 45(4):230-44. PubMed ID: 12125044
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain.
Vahid-Ansari F; Nakabeppu Y; Robertson GS
Eur J Neurosci; 1996 May; 8(5):927-36. PubMed ID: 8743740
[TBL] [Abstract][Full Text] [Related]
15. 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain.
Vahid-Ansari F; Robertson GS
Eur J Neurosci; 1996 Dec; 8(12):2605-11. PubMed ID: 8996810
[TBL] [Abstract][Full Text] [Related]
16. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
18. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice.
Airavaara M; Planken A; Gäddnäs H; Piepponen TP; Saarma M; Ahtee L
Eur J Neurosci; 2004 Nov; 20(9):2336-44. PubMed ID: 15525275
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields.
Dilts RP; Helton TE; McGinty JF
Synapse; 1993 Mar; 13(3):251-63. PubMed ID: 8497810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
